Showing results (91-100 of 614) with videos related to
Sort By:
Pageof 62
Nephrologie & Therapeutique|November 21, 2007
[Abnormalities of renal sodium transport and blood pressure sensitivity to salt]M BurnierThe American Journal of Cardiology|May 4, 2001
Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular diseaseH R BrunnerExpert Opinion on Investigational Drugs|January 5, 2002
Novel angiotensin II inhibitors in cardiovascular medicineM BurnierHospital Practice (Office Ed.)|August 15, 1990
The renin-angiotensin system in hypertension: an updateH R BrunnerAmerican Journal of Hypertension|January 23, 1998
The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerationsH R BrunnerAmerican Journal of Hypertension|June 2, 1998
Endothelin inhibition as a biologic target for treating hypertensionH R BrunnerRevue Medicale Suisse|October 6, 2006
[Lercanidipine, a third generation calcium antagonist. Which advantages?]P Meier, M BurnierClinical Pharmacokinetics|May 1, 1992
Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapyM Burnier, J BiollazDrug Safety|August 5, 1999
Comparative safety and tolerability of angiotensin II receptor antagonistsL Mazzolai, M BurnierHand Surgery & Rehabilitation|November 29, 2016
[Radiological analysis of acute distal radius fractures and clinical outcomes]G Herzberg, M BurnierPageof 62